Devices, needles & plasma · information, not advice
The light gets sold harder than it gets studied
Wavelength Scalp reads the non-drug hair-loss industry — laser caps, red light, PRP, microneedling, exosome pitches — against the trials, FDA records and price tags behind it. Written from published sources; reviewed by no clinician; never medical advice.
Our grading of what the published record holds — trial design and regulator status, never a promise about your scalp. Four rings is drug-approval-grade evidence; zero is none.
Latest readings
All readings →Laser Treatment for Hair Loss: In-Clinic Sessions vs an At-Home Cap
Office laser hoods and home caps share one FDA product code. What the clearances say, the break-even maths, and where a clinic helps.
Reading →11Oct 26, 2026PRP Hair Treatment Side Effects and Aftercare: What's Normal and What Isn't
Soreness is expected after scalp PRP. The rare reactions worth a same-day call, who is told not to have it, and where aftercare sheets disagree.
Reading →10Sep 16, 2026PRP After a Hair Transplant: The Add-On, Examined
Clinics bundle PRP into transplant aftercare at standalone prices. The evidence for the add-on is thinner than for PRP itself — here's how to interrogate the bundle.
Reading →09Sep 14, 2026Stem-Cell Hair Treatments: Reading the Red Flags
The only FDA-approved stem-cell products treat blood disorders, not baldness. How scalp stem-cell offers are structured, and the flags the FDA taught patients to spot.
Reading →08Sep 11, 2026Exosomes for Hair Loss: What the FDA Warning Says
There are no FDA-approved exosome products — the agency said exactly that after patients were hospitalized. What clinics are selling, and the questions that expose it.
Reading →What this site does
One niche of the hair-loss market sells physics and procedures instead of pills: red-light caps and helmets, platelet-rich plasma injections, microneedling rollers, and — at the far end — exosome and stem-cell offers the FDA has warned patients about by name. Prices run from a $30 roller to four-figure devices and multi-thousand-dollar injection courses, while the evidence underneath runs from modest sham-controlled trials down to nothing at all. Wavelength Scalp exists to keep those two scales in the same view.
The method is narrow on purpose. Every efficacy statement on this site is an attributed, dated quote or figure from a named source — a journal trial, an FDA database entry, a regulator's letter, a vendor's own store page — and anything we could not verify at its source is left out rather than softened into a hedge. The red band the devices sell sits around 655 nm, because that is the wavelength the published trials actually used; when a brochure claims more than its trial record holds, we say whose claim it is and what the record holds instead.
Where to start
If a device is on your mind, start with the laser cap for hair growth assessment: four cleared devices, their real 510(k) numbers, dated store prices, and the two trials the whole category leans on. If a clinic is pitching injections, the PRP hair treatment explainer walks through the procedure, the session schedule clinics sell, the published cost figures and the meta-analysis certainty grades — with no clinic linked, ever. The readings then go one question at a time: what “FDA-cleared” is worth, what a PRP course costs, and why exosome offers are a warning-letter category.
What we refuse to do
- No before/after photos, no testimonials, no invented percentages — if a number has no named source, it has no place here.
- No clinic links, rankings or recommendations for PRP, exosome or stem-cell providers, paid or otherwise.
- No dosing or how-to-treat instructions; trial protocols are described as what a trial did, and treatment decisions are routed to clinicians.
And one sentence we repeat because it is true: the strongest-evidence options in hair loss remain the approved drugs a pharmacy or a prescriber can give you. A device or a procedure deserves comparison against that baseline — and a diagnosis deserves a doctor before either.